Here’s a breakdown of the vaccination campaign in Extremadura,Spain,as detailed in the text,categorized for clarity:
1. influenza (flu) Vaccination
* Global for Seniors: Offered to all individuals 60 years and older in extremadura – a first for an autonomous community in Spain. This aims to prevent hospitalizations and serious illness.
* Expanded Childhood Cohort: Recommended for children aged 6 months to January 1, 2020 (previously a narrower age range).
* Vaccine Type (Children):
* 6-23 months: Vaxigrip (intramuscular injection)
* 24 months – January 1,2020: Fluenz (intranasal spray) – preferred for better mucosal immunity and easier acceptance.
* Goal (Childhood): Reduce infections, school absences, and parental work leave.
* Other Groups: Also offered to people with chronic diseases, pregnant women, cohabitants of immunosuppressed individuals, and healthcare/social care workers exposed to animals.
2. COVID-19 Vaccination
* Target Age: Recommended from age 70, due to decreased circulation and concentrated serious illness in older adults.
* High-Risk groups: People with transplant history,immunosuppression,serious chronic diseases,pregnant women,residents of social health centers,healthcare personnel,and cohabitants of vulnerable individuals.
* Timing: Available any time of the year, with a minimum of 3 months since the last dose or infection.
* Vaccines Available:
* Comirnaty (Pfizer) – adult doses, adapted to current strains.
* Pediatric and mini-pediatric doses of Comirnaty.
* Bimervax (Hipra) – protein vaccine.
* Doses Available: 115,000 adult, 1,050 pediatric, 400 mini-pediatric, and 16,680 protein doses.
* Location: Local health center,clinic,or nearest center for mutual members.
3. RSV (Respiratory Syncytial Virus) Vaccination
* First-Time Implementation: Extremadura is pioneering this vaccination.
* Target Groups:
* Individuals 60 and over institutionalized in nursing homes.
* People with lung transplants.
* Goal: Reduce morbidity and mortality from RSV in vulnerable adults.
* Timing: Begins in November.
* Doses: 15,000 doses acquired (investment of almost €2 million).
Key Highlights & Overall Campaign Focus
* pioneering Approach: Extremadura is positioning itself as a leader in respiratory disease prevention.
* Investment: Nearly €6 million invested in the campaign.
* Accessibility: Efforts to improve coverage and facilitate access to vaccines.
* coordinated Strategy: A comprehensive plan using adapted vaccines.
* Focus on Vulnerable Populations: Prioritizing the health of seniors, those with chronic conditions, and immunocompromised individuals.